Blaize investors face October 5 deadline in $20 million revenue suit

Blaize Holdings investors have until Oct. 5 to seek lead plaintiff in a securities class action over a $20 million revenue claim that deepened after guidance was cut 68 percent.

"The complaint alleges that Blaize announced transactions with entities wholly unequipped to conduct meaningful business in order to create an appearance of growth," Faruqi & Faruqi, LLP said in a Sept. 3 statement, one of at least nine firms — including Rosen Law Firm, Kaplan Fox & Kilsheimer and Robbins LLP — soliciting class members before the deadline.

The suit centers on the $20 million Blaize booked as fourth-quarter fiscal 2026 revenue from NeoTensr, an entity incorporated in December 2025 with roughly $2 million in startup capital. Blaize had said the agreement could generate up to $50 million. On April 28, Pelican Way Research published a short report alleging Blaize inflated its share price through the deal, whose website featured products that appeared to carry a photoshopped Blaize logo. Blaize shares fell 12.03 percent to close at $1.90 that day.

The legal exposure widened Aug. 13, when Blaize cut full-year revenue guidance to $40-43 million from $130 million, citing commercial opportunities that "did not materialize as expected." Shares traded below $0.64 on Aug. 14, more than 65 percent below the May public offering price of $1.85. Investors who bought between July 18, 2025 and April 28, 2026 must move the court by Oct. 5 to serve as lead plaintiff, the role that directs settlement negotiations on behalf of the class.

Customer concentration behind the shortfall

Blaize's Form 10-Q showed the revenue miss traces to two partners. NeoTensr issued only one $13.7 million purchase order against the April agreement, which Blaize amended Aug. 7 into a take-or-pay contract with a minimum purchase commitment; a separate $23.8 million NeoTensr receivable was paid in full, driving second-quarter momentum. Starshine, another customer, issued a single $10.4 million purchase order of which $8.8 million remained unpaid. Blaize fully reserved that receivable, transferred it to its wholly owned Chinese subsidiary and said it would not engage further with Starshine unless the balance was settled. The company also dropped its previously reported pipeline metrics as a key business measure, saying they were "not as closely connected with future revenue as previously expected."

What the deadline decides

The court-appointed lead plaintiff — the investor with the largest financial interest who is adequate and typical of the class — controls litigation strategy and counsel selection, giving it outsized sway over any settlement. Rosen Law Firm, which first filed the suit, cites its No. 1 ranking by ISS Securities Class Action Services for 2017 settlements and the $438 million it recovered for investors in 2019; Kaplan Fox says it has recovered more than $10 billion since 1956. Class members who skip the role can still share in any recovery as absent members, and no class has been certified.

The outcome carries direct consequences for Blaize's balance sheet. With the stock down more than 65 percent from its May offering price and near-term revenue visibility resting on the NeoTensr take-or-pay structure rather than organic orders, a settlement or adverse judgment would compound the cash strain from the fully reserved Starshine receivable. The Oct. 5 deadline also opens the door to SEC scrutiny of the revenue recognition, which could extend the legal overhang beyond the private action and weigh on Blaize's ability to line up fresh financing or partnerships at a time when its shares trade near $0.64.

This article is for informational purposes only and does not constitute investment advice.